Navigation Links
Research!America Honors Univ. of Chicago Economists for Study Showing Economic Impact of HIV/AIDS Drug Development
Date:10/9/2007

WASHINGTON, Oct. 9 /PRNewswire-USNewswire/ -- Research!America today presented its 2007 Eugene Garfield Economic Impact of Medical and Health Research Award to two University of Chicago economists. Tomas Philipson, Ph.D., and Anupam Jena, Ph.D., were honored for their study "Who Benefits from New Medical Technologies?" published in Forum for Health Economics and Policy.

Using a novel approach, Philipson and Jena measure the value of HIV/AIDS drugs developed from 1980 to 2000. They calculate nearly $1.4 trillion in total value -- past and future -- to consumers from these drugs, based on the resulting gains in survival. They also estimate past and future profits for producers of the drugs to be nearly $63 billion -- or 5% of the total value. The authors conclude that such relatively low profits could reduce the incentive for producers to develop future HIV/AIDS treatments. They recommend exploring ways to raise the value to producers of new medical technologies in order to encourage further innovation.

Mark McClellan, MD, Ph.D., former Centers for Medicare and Medicaid Services administrator, and Eugene Garfield, Ph.D., the award benefactor, presented the award to Philipson and Jena today in Washington, DC. The award is named for Garfield, president and founding editor of The Scientist and creator of the Science Citation Index. McClellan headed the award selection committee. Both are Research!America board members.

Presenting the award, McClellan noted the contributions of past recipients and the need to build on their work.

"While the opportunity to understand and prevent disease and its complications has never been greater, the challenge for promoting effective, efficient use of increasingly diverse and sophisticated treatments has also never been greater," he said. "Expanding our knowledge of the economic impact of medical and health research will help overcome the challenges on the path to better health that we all know lies ahead."

Citing the importance of the Garfield Award in encouraging further study in this area, Mary Woolley, Research!America's president, said, "We need much more work like that of Dr. Philipson and Dr. Jena to show how important health-related research is for our nation's economy as well as our length and quality of life."

About the 2007 Recipients

Tomas Philipson, Ph.D., is a tenured professor in the Irving B. Harris Graduate School of Public Policy Studies at the University of Chicago. He is also a faculty member of the university's Department of Economics and its Law School. One of the nation's leading experts in the field of health economics, he has served as a senior economic adviser to the U.S. government.

Anupam Jena completed his Ph.D. in economics at the University of Chicago in 2006 as part of the University's Medical Scientist (MD/Ph.D.) Training Program. He is currently a third-year medical student at the University of Chicago and a Bing Center Visiting Fellow at the Rand Corporation. His research has focused on the economic value of medical innovation, implications of cost-effectiveness policies for technological growth and the economics of fertility.

About Research!America

Research!America is the nation's largest not-for-profit public education and advocacy alliance working to make research to improve health a higher national priority. Founded in 1989, Research!America is supported by more than 500 member organizations that represent the voices of more than 125 million Americans.

Ms. Woolley is available for further comment.


'/>"/>
SOURCE Research!America
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. US Academy honors 15 for major contributions to science
2. American Cancer Society Honors Exemplary Cancer Caregivers
3. Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan
4. Baltimore is Americas Fittest City; Chicago the Fattest
5. Chicago :FDA imposes Ban on Biomedical Tissue Services
6. Chicago: Dad, I need you desperately, Please come back
7. Couples To Swap Kidneys In Chicago
8. Funds Allocated to Illinois and Chicago to Prepare in Case of a Flu Pandemic
9. Food Poisoning at the Chicago Food Festival
10. Rural Canadians travel far for specialists: study
11. A new study surpasses Gene Therapy Hurdle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: